In a 2-yr carcinogenicity bioassay, 0, 2, 4, or 8 mg furan/kg body weight (BW) was administered to male and female Fischer (F344) rats and resulted in an 86-100% incidence of cholangiocarcinomas with occasional metastasis. In a separate but concurrent study, male F344 rats dosed with 30 mg furan/kg BW for 90 days developed marked cholangiofibrosis and cholangiohepatitis and, when subsequently maintained without further treatment for an additional 6, 12, or 18 months, the cholangiofibrosis progressed to yield a 100% incidence of cholangiocarcinomas. Transplantation of 21 primary cholangiocarcinomas into syngeneic recipients resulted in growth from 4 donors. The 4 transplanted lines were successfully transferred through 8 serial passages and resulted in metastases in the recipients. The progressive growth of these proliferative hepatocholangial lesions over time, their transplantability, and the development of metastases in some of the cases provide biological evidence of the malignant potential of the furan-induced liver changes.
INTRODUCTION
Diverse chemicals, based on the oxygen-containing heterocyclic furan ring, comprise a large class which includes industrial chemicals, drugs, and a number of naturally occurring compounds found in terrestrial and marine organisms and plants. Furan, the parent compound for this chemical class, is an important industrial chemical used primarily as an intermediate in the synthesis and preparation of other organic compounds. Because of the absence of data on the consequences of long-term exposure to furan, the National Toxicology Program (NTP) has conducted a 2-yr study to evaluate the carcinogenic potential of furan in rats and mice. Although the detailed results of the NTP 2-yr studies have not been published as yet, a treatment-related increased incidence of hepatocellular neoplasms was observed in B6C3F1 mice (22) . Recently, studies on unscheduled DNA synthesis, progression of pathologic changes in the liver, and quantitation of hepatocyte proliferation have been studied in Fischer 344 (F344) rats and B6C3F, mice given single and repeated gavage doses of furan for up to 6 weeks (30) .
During prechronic studies, rats that received 30 mg of furan/kg of body weight (BW) for 90 days developed nodular hepatic lesions comprised of proliferating bile duct epithelial cells with accompanying fibrosis and destruction of hepatic parenchyma. These lesions are compatible with descriptions of chemically-induced alterations that have been previously called cholangiofibrosis, adenofibrosis, cholangiohepatitis, toxic hepatitis, toxic cholangitis, and cholangiofibroma (1, 5-7, 11-13, 17-19, [23] [24] [25] 27) . Their potential to progress to malignancy is unknown. Furthermore, the distinction between cholangiofibrosis, cholangiofibroma, and cholangiocarcinoma has not been clearly defined. In order to investigate whether the furan-induced bile duct proliferation would regress or progress to malignancy after cessation of chemical exposure, a group of male rats was treated with furan for 90 days and then maintained without chemical exposure for an additional 6, 12, or 18 months (&dquo;stop study&dquo;). Transplantation studies using biliary proliferative liver nodules obtained from &dquo;stop study&dquo; rats as well as from rats after 2 yr of continuous exposure to furan (2-yr carcinogenicity study) were carried out in syngeneic recipients to further characterize the biological behavior of these lesions. The purpose of this report is to characterize the progressive evolution of these proliferative furan-induced liver lesions and to document the transplantability of the lesions.
MATERIALS AND METHODS

2-Yr Study
The 2-yr study consisted of groups of 70 male and 70 female F344 rats (Charles River Breeding Laboratories, Kingston, NY) that received 2, 4, or 8 mg of furan/kg of BW by gavage in com oil (5 ml/kg) or only corn oil (vehicle controls) 5 days per week. Rats were 7-8-weeks-old at the start of the study.
Ten male and 10 female rats from each group were designated for interim sacrifice and necropsied at 9 and 15 months after commencement of treatment (see Table I ). All remaining rats were necropsied 104 weeks after commencement of treatment.
&dquo;Stop Studies&dquo;
Fifty 6-week-old male F344 rats (Charles River Breeding Laboratory, Kingston, NY) were gavaged 5 days per week with 30 mg furan/kg BW in corn oil (5 ml/kg). Ten treated rats were necropsied at the end of 90 days (65 days of dosing) and the remaining 40 treated males were then held without further treatment. Ten of these previously treated rats were killed at 9 and at 15 months, respectively, after commencement of treatment (see Table I ). There was one early death prior to the 9-month sacrifice and 6 early deaths between the 9 and 15 month sacrifice intervals. The 14 remaining treated rats died or were killed when moribund prior to the 21 st month of the study.
Transplantation Studies
Weanling male and female F344 rats (Frederick Cancer Research Center, Frederick, MD) were used as transplantation recipients. After a quarantine period, the rats were randomly assigned as recipients and housed separately in polycarbonate cages. A total of 21 primary cholangiocarcinomas, used for transplantation, were obtained from male rats in the &dquo;stop study&dquo; or from male and female rats killed at the termination of the concurrent 2-yr carcinogenicity study.
Freshly removed tumor samples were obtained as aseptically as possible and placed in petri dishes with cold tissue culture medium 199 (Gibco, Grand Island Biological Co., Grand Island, NY). Tumor tissue was diced (4 mm cube) into 30-50 mg fragments using sterile scalpels and placed in sterile covered petri dishes on ice until injected. A single tumor fragment was drawn into a 10 gauge trocar and injected subcutaneously near the right axillary area within 30 min from the time of being harvested. Each of the 21 primary lesions was transplanted into 5-10 recipients (Passage I), the exact number depending upon the availability of recipients. The same general procedure was used for 8 successive serial passages. Two samples of normal liver failed to grow when similarly transplanted into syngeneic recipients.
Transplant recipients were observed daily for clinical signs and palpated weekly for tumor growth at the transplantation site. When masses appeared, they were measured weekly and their sizes recorded. If, after approximately 6 months, recipients did not have evidence of transplant growth, they were necropsied and implantation sites were examined grossly. Recipients that became moribund or had large, ulcerated or hemorrhagic lesions were killed, tissues were fixed for histopathologic examination, and portions of the transplanted masses were injected into new transplant recipients.
Animal Husbandry
All rats were acclimated for 10-14 days to laboratory conditions. &dquo;Stop study&dquo; animals were housed 2 per cage and transplantation recipients were housed I per cage on hardwood bedding in polycarbonate cages. NIH-07 pelleted diet (Zeigler Bros., Gardners, PA) and water were available ad libitum. Husbandry conditions included a 12-hr light/dark lighting cycle, 50 ± 10% relative humidity, ambient temperature of 72.3 ± 1.1 OF, and 12 room air changes per hr.
Humane animal care measures were followed for all studies in accordance with published guidelines (16) .
Pathology Procedures
All rats that were found dead, killed when moribund, or killed at scheduled intervals were given a complete necropsy examination. A complete set of 40 representative tissues plus gross lesions was fixed in 10% neutral buffered formalin from the 2-yr study; liver, kidney, lung, and gross lesions from the &dquo;stop study&dquo; rats; and transplantation site, lung, axillary lymph nodes, liver, and grossly observed lesions from the transplant recipients. Trimmed tissues were routinely processed, embedded in paraffin, sectioned at approximately 6 microns and stained with hematoxylin and eosin. Selected tumor sections were stained with Bismarck Brown and periodic acid-Schiff to characterize the mucus present in dilated biliary glands.
RESULTS
2-Yr Study
A preliminary summary of neoplastic liver lesions from the 2-year study is presented in Table II which demonstrates the clear-cut carcinogenic responses in the liver. In 6 high dose (8 mg furan/kg BW) rats with cholangiocarcinomas, distant metastases were observed in pancreas, adrenal capsule, ovarian serosa, abdominal blood vessels, pancreatic lymph node, diaphragm, mediastinal lymph node, and lung at the final sacrifice. Complete pathologic and toxicologic results will be published by the NTP subsequent to final peer review of the study. The gross and microscopic features of the liver lesions were similar to those observed in the interim sacrifice animals (see below).
Liver Lesions at 9-and I S-Month Sacrifices
Livers from male and female rats treated with 2, 4, or 8 mg furan/kg BW for 9 or 15 months were grossly enlarged, had a rough, pitted surface with a prominent lobular pattern, and were severely distorted by multicentric grayish-white nodules, multiple reddish-brown hepatic nodules and areas of scarring. The magnitude of the gross liver lesions reflected the dose level of furan received and the duration of treatment. At both interim sacrifice intervals, the nodular and fibrotic changes in the liver were most dramatic in the left lateral, caudate, and right posterior liver lobes, especially on the visceral liver surfaces that rested on the forestomach (Fig.  1 a) . In animals receiving 2 or 4 mg furan/kg BW for 9 months, small (2-5 mm) grayish-white nodules and scarring were usually restricted to the lateral and posterior margins of the left lateral and caudate lobes. Similar but larger ( I-5 cm) grayish-white nodules were observed in high-dose (8 mg furan/kg BW) animals at the 9-month and in all dose groups at the 15-month interim sacrifice. These discrete nodules were well delineated from the surrounding liver and were generally multiple, cystic proliferations that were irregularly oval and light tan or grayish-white in color. Cut surfaces of these firm masses were white and glistening with cysts being more evident and larger at the periphery of the masses. Cystic fluid was clear and slimy to viscous.
A constellation of nonneoplastic lesions was observed in all treated rats at each necropsy interval.
In general, all treated rats had multiple liver lesions. Liver lesions were more severe in higher dosage groups and, within a given dosage group, lesions were more severe at 15 months than at 9 months.
Cholangiocarcinomas, accompanied by cholangiohepatitis, were observed at 9 and 15 months in all treated groups.
The constellation of non-neoplastic liver changes, collectively categorized as cholangiohepatitis, involved hepatocytes, Kupffer cells, and the biliary tract ( Fig. 1 b) . Alterations in hepatocytes consisted of cytomegaly, cytoplasmic vacuolization, degeneration, necrosis, and nodular regenerative hyperplasia. There was biliary tract fibrosis, hyperplasia, chronic inflammation, and multiple dilated biliary glands. A brown to green pigment deposition was observed in Kupffer cells and macrophages. The normal hepatic architecture was distorted by alternating areas of hypertrophy and nodular regenerative hyperplasia of hepatocytes and by areas of cholangiofibrosis ( Fig. 1 c) . Necrosis and cytodegeneration were evident within the nodules of hepatocellular hyperplasia. Fibrosis, chronic inflammation, and bile duct proliferation were so extensive in some areas that hepatocytes were not found or only small islands of hepatocytes were observed. There were dense deposits of mature collagen in some areas of fibrosis. Relatively normal and dysplastic biliary epithelium, forming dilated glands and associated oval cell hyperplasia, totally replaced proliferative lesions (Fig. 1 d) . In the advancing edges . of the proliferative lesions, early fibroplasia without : extensive collagen deposition and lymphocytes were : admixed with numerous oval cells ( Fig. 1 d) .
The large grayish-white multicystic bosselated masses observed grossly were diagnosed as cholangiocarcinomas. The cholangiocarcinomas consisted of a connective tissue stroma, which was dense in some areas, interspersed between multiple biliary glands and cysts (markedly dilated glands) lined by biliary epithelial cells that varied considerably in morphologic features (Figs. 1 e and 2a ). Epithelial cells were flattened in some areas and cuboidal to columnar in other areas. Some had bizarre shapes.
The cytoplasm of these neoplastic epithelial cells was basophilic and there was pronounced nuclear hyperchromasia. Epithelium lining dilated glands was occasionally piled up and mitoses were sometimes numerous. In some dilated neoplastic glands, the lining epithelium was partly or completely missing ( Fig. 2a ). Mucous-secreting epithelial cells that were interspersed among the other cells lining the cystic glands and the contents of the cysts were periodic acid-Schiff and Bismark Brown positive, indicative of mucin production. Neovascularization was observed in some of the cystic spaces. Mast cells, lymphocytes, and neutrophils were present in the stroma in some areas and neutrophils were present in some cystic lumens. These proliferative epithelial growths infiltrated the adjacent hepatic parenchyma ( Fig. 2b) and occasional &dquo;metastatic&dquo; foci of cholangiocarcinoma were observed surrounded by hepatic parenchyma (Fig. 2c ). Dysplastic biliary epithelium (Fig. 2b, c) was observed throughout cholangiocarcinoma development as well as in discrete tumors seen at the end of the study. Liver Lesions in &dquo;Stop Study&dquo; Males &dquo;Stop study&dquo; males received 30 mg furan/kg BW for 90 days after which they received no further doses of furan. Rats sacrificed at 90 days had enlarged livers with a prominent lobular pattern and a granular surface texture. Grayish-white to tan areas of fibrosis were present along those edges of the liver in contact with the forestomach (see Fig. 1 a) . Microscopically, these livers were characterized by foci of hepatocellular hyperplasia separated by narrow intervening bands of fibrosis and bile duct hyperplasia which was most prominent along the edges of liver lobes in contact with the forestomach. Other histopathologic changes consistently found were cytomegaly, degeneration, necrosis, and nodular hyperplasia of hepatocytes, hyperplasia of bile ducts, pigmentation in Kupffer cells, and fibrosis. Nodular hepatocellular hyperplasia appeared to occur more frequently in the lateral lobes. Hyperplasia of bile ducts and cholangiofibrosis were more prominent in the right posterior and caudate lobes. &dquo;Stop study&dquo; rats sacrificed at 9 and 15 months had gross and microscopic liver changes that were similar in severity and extent to those seen at 90 days but were more severe than those seen in the rats continuously dosed with 8 mg furan/kg of BW for 9 or 15 months (see interim sacrifice liver lesions above). Cholangiocarcinomas that metastasized to pancreas, mediastinal and/or mesenteric lymph nodes, and spleen were observed in 2 &dquo;stop study&dquo; rats that died after the 15 month necropsy interval. Hepatocellular carcinomas were observed in the livers of 6 &dquo;stop study&dquo; rats with one of these metastasizing to the lungs.
Transplantation Studies
Liver lesions selected for transplantation consisted of 1-5 cm diameter discrete, irregularly oval, tan nodules that were well delineated from the surrounding liver. Subsequent histologic examination of these nodules confirmed that they all were cholangiocarcinomas with no discernible differences between lesions that were successfully transplanted and those that did not grow in recipients. Five cholangiocarcinomas obtained from &dquo;stop study&dquo; rats after the 9 month sacrifice and 16 cholangiocarcinomas obtained at the 2-yr final sacrifice were used for transplantation.
Growth at the implantation sites in recipients occurred for 4 of the original 21 primary neoplasms transplanted. Tables III and IV summarize the transplantation results and sizes of the 4 separate z (arrows) is present in the subcapsular proliferative response. H&E. Bar = 100 Am. c) Liver from a rat that received 30 mg furan/kg BW for 90 days There is extensive replacement of hepatic parenchyma by a proliferative cholangiofibrotic reaction. Bar = 260 Am. d) Cholangiocarcinoma in a male rat that received 30 mg furan/kg BW for 90 days followed by a 6-month -period without treatment. Hepatic parenchyma (still evident in the upper right edge) has been replaced by proliferating bile ducts, oval cells, and an early fibroplasia. Dilated biliary glands lined by uniformly flattened epithelium are present in the upper left and poorly formed biliary glands lined by hyperchromatic, dysplastic cells are present in the lower half of the photomicrograph. H&E. Bar = 100 am. e) Cholangiocarcinoma in the liver of a female rat that received 8 mg furan/kg BW for over 20 months. In this lesion, collagen and inflammatory cells separate mildly dilated biliary glands, many of which contain necrotic debris and inflammatory cells. H&E. Bar = 260 Am. FIG. 2. -Photomicrographs (H&E) 01 furan-induced cholangiocarcinomas in F344 rats. a) Liver from a female rat that received 8 mg furan/kg BW for 20 months. Dilated biliary glands partly lined by hyperchromatic epithelium are filled with a mucofibrinous material and occasional inflammatory cells. Intervening tissue consists of collagenous fibers admixed with lymphocytes. H&E. Bar = 100 Am. b) Liver from a male rat that received 30 mg furan/kg BW for 90 days followed by a 6-month-period without treatment. Note the invasion of proliferating biliary glandular structures into the adjacent hepatic parenchyma. H&E. Bar = 100 Am. c) Liver from the same rat as in Fig. 2b . In this area, there is a dilated biliary gland (top center) filled by necrotic debris and surrounded by an irregular band of connective tissue. The hepatic tumor lines. The 4 tumor lines were successfully transplanted into recipients through 8 serial passages. In Passage II, additional recipients were utilized to determine if the tumor could be transferred from one sex to the other. Tumors developed at the implantation sites of opposite sexes with no apparent change in growth rate. With enlargement of the transplanted tumors, the overlying skin became ulcerated. Histomorphologic features of the transplant growths were similar to those of the original neoplasms (Fig. 2d ) and the transplanted tumors did not become less differentiated or more anaplastic over the course of the 8 serial passages.
For the 4 original primary lesions that were successfully transplanted over the 8 passages, 183/205 (89.3%) recipients developed tumors at the implantation site and 12 (6.6%) had metastatic lesions in the axillary lymph nodes, lungs ( Fig. 2e) , and/or liver. Metastases occurred in 2 of the 4 transplantable tumor lines and the number of recipients with metastases increased with successive passages. One tumor line had metastases in 1 animal in Passage III, 1 animal in Passage IV, 3 animals in Passage VII, and 4 animals in Passage VIII. A second tumor line had metastases in 1 animal in Passage V and in 2 animals in Passage VI. Histomorphologic features of the metastatic lesions were similar to the transplanted growth.
Morphologic Features of the Transplanted Growths
Transplanted masses were firm and partially circumscribed from the subcutaneous tissues, but firmly adherent to the overlying skin. Histologically, evidence of local invasion into the subcutis and dermis was often evident. Otherwise, the gross and microscopic features of the transplanted tumors and their metastases were identical to the primary neoplasms in the donors.
DISCUSSION
Treatment of rats with chemical agents may be associated with progressive development of complex degenerative, inflammatory and proliferative hepatocholangial lesions, including neoplasms. Bile duct proliferative lesions and cholangiofibrosis (ad- enofibrosis) have been reported following treatment with coumarin (8), polychlorinated biphenyls (9, 11-13), butter yellow (5, 19) , congeners of butter yellow, thioacetamide, N,N'-nitrosomorpholine (2), methapyrilene (17) and aflatoxin (4). These lesions have been described and variously classified as cholangiofibrosis, adenofibrosis, intestinal cell metaplasia, or cholangiolar mucopolysaccharidosis. Bannasch et al (1) have described the pathogenesis of these proliferative hepatic lesions following exposure of rats to N-nitrosomorpholine. According to these investigators, hepatic toxicity initially results in hepatocellular necrosis with development of reactive proliferation of biliary and mesenchymal cells, resulting in cholangiofibrosis and cholangiolar mucopolysaccharidosis and eventual development of cholangiofibrosis. Depending upon the dose of carcinogen used and the duration of exposure, cholangiofibrosis may progress to cholangiofibroma, cystic cholangioma, or cholangiocarcinoma (1). The histomorphologic features of degenerative, inflammatory, and proliferative components of these lesions are similar, making definitive diagnosis diflicult. The toxicological and biological significance of these lesions remains unknown. Identification of similar hepatobiliary lesions in the 90-day furan study prompted our studies to further define the biological behavior of the induced hepatic changes. Similar to the changes described for the several hepatocarcinogens indicated above, the furan-induced hepatic lesions included concomitant parenchyma is being disrupted by the proliferative response. Islands of dysplastic, hyperchromatic biliary cells (arrows) are present. H&E. Bar = 50 Am. d) Low power photomicrograph of a cholangiocarcinoma a few weeks after transplantation into the subcutis of a syngeneic recipient. The epidermis is at the top. The subcutaneously growing neoplasm consists of irregular biliary glands that are filled with necrotic debris and inflammatory cells and are separated by bands of connective tissue. The histomorphologic features of this neoplasm are identical to the primary cholangiocarcinoma that was transplanted. H&E. Bar = 260 ~m. e) Metastatic cholangiocarcinoma in the lung (normal lung tissue at upper right) from a transplant recipient. Histomorphologic features of this metastatic neoplasm are identical to those of the primary cholangiocarcinoma in the donor and to the subcutaneous transplant on the back of this recipient. H&E. Bar = 100 ALm. While there were no qualitative differences in the proliferative cholangial liver lesions in the various groups of rats throughout the study, the severity and extent of these changes increased with dose and duration of exposure. Histologically, changes were always expansive, proliferative and locally infiltrative rather than being atrophic and contractive as has previously been described for similar changes induced by other chemicals (1, 4, 10-12, 17, 23, 25) .
Based upon examination of mild and severe lesions throughout the course of these studies with furan, it appeared that the process started with necrosis of hepatocytes and was associated with an early and persistent oval cell proliferation. As treatment continued, there was always some degree of toxic cholangiohepatitis. However, within the first 13 weeks of exposure to 30 mg furan/kg BW, there was a significant bile duct proliferation with an attendant connective tissue proliferation. Varying degrees of inflammatory cell infiltration were observed with neutrophils and fibrinous material present in lumens of dilated proliferative biliary glands. The green-brown pigment associated with these lesions is believed to be lipofuscin as previously described (11) . As a function of dose or duration of exposure, the morphologic features of the proliferating biliary epithelium became irregular, metaplastic, dysplastic, and eventually neoplastic. Accompanying the constellation of nonneoplastic liver lesions, cholangiocarcinomas were present in all furan-treated groups at the 9-month interim sacrifice and thereafter.
The histomorphologic and biological features of the furan-induced lesions provide evidence that these changes were essentially malignant or premalignant in all stages investigated in this study. This opinion is in contrast to similar lesions being regarded as preneoplastic or benign (1, 17) . Morphological fea-tures such as intrahepatic infiltration and micro invasion (disruption of basement membranes of glandular formations), absence of histologic evidence of regression, formation of branched or anastomized glands, piling up of epithelial cells lining glandular lumens, nuclear hyperchromasia and cellular dysplasia, increased mitotic figures, and compression of surrounding hepatic parenchyma lend support to the potential malignancy of the proliferative cholangial lesions. The biological evidence that these lesions are malignant is more convincing. The cholangial lesions are considered to be autonomous with progressive growth after cessation of treatment as demonstrated in the &dquo;stop study.&dquo; Furan has been found not to bioaccumulate in the liver following multiple doses; it is metabolized to reactive species, primarily in the liver, and these intermediates react with protein (3) . Some of the primary neoplasms observed in animals treated for up to 2 yr metastasized. More metastases might have occurred if the animals had lived longer. The cholangiocarcinomas and their metastases were morphologically identical to cholangiocarcinomas in the livers of other rats where there was no evidence of metastasis. Finally, the successful transplantation of some of these tumors with progressive growth and metastasis in recipients provides additional evidence for the malignant nature of the furan-induced cholangial lesions. Similar transplantation studies have been previously undertaken to help define the biological behavior of similar (17) or other tumors in F344 rats (15, 28, 29) . On the average, the cholangiocarcinomas in the present study grew to 30 mm in greatest dimension in 11.2-13.5 weeks. Thus, their growth rate was similar to that reported for transplanted basal cell tumors of the skin (10.1-15.7 weeks to reach 30 mm in greatest dimension) but less than the growth rate reported for squamous cell carcinomas of the skin (3.1-4.7 weeks to reach 30 mm in greatest dimension) or preputial gland carcinomas (7.1-9.7 weeks to reach 30 mm in greatest dimension) in F344 rats (15) . The histologic appearance of the transplanted cholangiocarcinomas remained similar to that of the original tumors and did not become anaplastic or less differentiated over the 8 serial passages. Similar results have been noted with transplants of liver tumors in the rat (21 ) and mouse (14) , epidermal squamous cell carcinomas in the rat (26) and with rat thyroid tumors (20) . The latter investigators noted no change in the morphology of the transplanted tumors until as late as the 16th passage or more, well beyond the scope of this study. In contrast to our findings, methapyrilene-induced proliferative cholangial lesions from the livers of Fischer 344 males, although morphologically similar to those induced by furan, did not grow when transplanted into syngeneic recipients (17) .
Exposure of male rats to 30 mg furan/kg BW for 13 weeks followed by several months without further treatment resulted in a proliferative toxic cholangiohepatitis and development of hepatic cholangiocarcinomas in all rats. Similar changes occurred in male and female rats exposed to 2, 4, or 8 mg furan/kg BW for up to 2 yr. Cholangiocarcinomas were diagnosed as early as 9 months in all 4 dosage groups. Early proliferative changes had histomorphologic features that were qualitatively similar to those seen in larger nodular lesions that grew after transplantation and metastasized in treated rats as well as in transplant recipients. Consequently, these proliferative cholangial lesions are considered to be malignant or potentially malignant.
